Channel Therapeutics Corporation

Contributing Author

Recent Articles by Channel Therapeutics Corporation

Jul-02	Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement GlobeNewswire
Jun-27	Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement GlobeNewswire
May-14	Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models GlobeNewswire
May-01	Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules GlobeNewswire